Midgard Science

IRBM

Pomezia, Italyirbm.comFrom their website, Nov 2026

Work here? Claim this listing

About

IRBM is a drug discovery research organization in Pomezia, near Rome, Italy. It supports programs from target validation through preclinical candidate selection across small molecules, peptides, antibodies, and cell therapy, serving pharmaceutical companies, biotech firms, foundations, and other research partners. Its work covers chemistry, biology, DMPK, in vivo pharmacology, structural biology, and specialized disease-area assays.

Services

  • Integrated drug discovery projects

    Runs coordinated programs from target validation through preclinical candidate selection on a single site with one team.

  • Small molecule discovery

    Advances small molecule programs from screening hits to preclinical candidates.

  • Medicinal chemistry

    Designs, makes, tests, and analyzes compounds through iterative DMTA cycles to optimize chemical series.

  • Synthetic chemistry

    Develops synthetic routes, parallel synthesis, scale-up, and purification to produce target compounds and libraries.

  • Computational chemistry

    Uses structure-based and ligand-based in silico methods to support target analysis, hit identification, hit-to-lead, and lead optimization.

  • Peptide discovery

    Develops peptide programs from starting sequence to candidate, including macrocyclic, complex, and protein peptides.

  • Antibody discovery

    Identifies, characterizes, and validates monoclonal antibodies.

  • Display technologies

    Provides peptide phage display, antibody phage display, and mRNA display for discovery workflows.

11 more services
  • Assay development
  • High throughput screening
  • High content screening
  • Biophysical approaches
  • Functional genomics
  • Protein production
  • NMR
  • DMPK
  • In vivo pharmacology
  • Spatial biology
  • Bioinformatics
Lead time
Results become a decision within days
What to send
  • Target hypothesis and the disease context behind it
  • a validated target and an assay ready to run at scale
  • Compound collections
  • Confirmed hit
  • Sequence

Capabilities

As they state on their website or in their listing.

Processes
  • Small molecule
  • Antibody
  • Peptide
  • Cell therapy
  • Recombinant protein
  • In vivo
6 more
  • Phage display
  • ADME
  • NMR
  • HTS
  • High-content imaging
  • Bioanalysis
Capacity
  • Compound collection of more than 400,000 high quality molecules
  • Single research hub in Rome, Italy
Data supplied
NMR · HPLC

Equipment

  • 400 MHz spectrometer
  • 500 MHz Bruker spectrometer
  • 600 MHz Bruker spectrometer
  • Biotage purification stations
  • HPLC
  • Mass spectroscopy instruments
  • UPLC

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

  • AAALACSelf-reported

Company

Type
CRO
Founded
2019
Quality
Code of Ethics · Policies and Certifications · Environmental, Health and Safety Policy · Energy Policy · Diversity and Inclusion Policy · Gender Equality Policy

Locations

Based in
Pomezia, Italy
Sites
Pomezia (Rome), Italy · Rome, Italy
Serves
Italy, Europe, worldwide

Contacts

Public records

Wikidata
Q24933575 source

Similar labs